Companies: 10,795·Total market cap: $144.5T
Warby Parker Inc.

Warby Parker Inc.

WRBYNYSEHealthcare● Active
$23.51
+$0.79(+3.48%)
Market Cap$2.9B
P/E Ratio
52W High$31
52W Low$14.96
Overview

Warby Parker Inc. (WRBY) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

wrby · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Warby Parker Inc. (WRBY) measures how much investors pay for each dollar of the company's trailing earnings. WRBY's current PE ratio of 2156.04x is calculated by dividing its stock price of $23.51 by its TTM earnings per share of $0.01. +32.4% elevated vs 5Y avg 1628.9x

2156.04x
P/E Ratio (TTM)+32.4%

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
48.36x
FY2026 est. EPS $0.49
Based on 7 analysts
EPS (TTM)
$0.01
TTM · diluted EPS
PEG Ratio
2.55
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Warby Parker Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2019 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 1628.9x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Instruments & Supplies · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Warby Parker Inc.
Warby Parker Inc.You
WRBY
$2.9B2156.04x+120.6%$0.01
Beam Therapeutics Inc.
Beam Therapeutics Inc.
BEAM
$3.1BN/A-$0.81
Bausch Health Companies Inc.
Bausch Health Companies Inc.
BHC
$1.9B16.14x-98.3%$0.43
Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc.
CON
$3.3B14.42x-98.5%$1.36
Haemonetics Corporation
Haemonetics Corporation
HAE
$3.4B26.20x-97.3%$2.06
ICU Medical, Inc.
ICU Medical, Inc.
ICUI
$3.4B4802.44x+391.5%$0.03
Integer Holdings Corporation
Integer Holdings Corporation
ITGR
$3.1B26.51x-97.3%$2.96
Industry Average
5 peers with valid PE
977.14xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 7 of 7 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
1628.87x$0.01
2024-12-31
FY2024
$-0.17
2023-12-31
FY2023
$-0.54
2022-12-31
FY2022
$-0.96
2021-12-31
FY2021
$-1.27
2020-12-31
FY2020
$-0.50
2019-12-31
FY2019
$0.00

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Warby Parker Inc. (WRBY) measures how much investors pay for each dollar of the company's trailing earnings. WRBY's current PE ratio of 2156.04x is calculated by dividing its stock price of $23.51 by its TTM earnings per share of $0.01.

PE Ratio = Stock Price ÷ EPS (TTM)
= $23.51 ÷ $0.01 = 2156.04x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

WRBY pe ratio · 6 questions

WRBY's current PE ratio is 2156.04x as of 2026-06-08, based on a stock price of $23.51 and TTM EPS of $0.01. Data sourced from Financial Modeling Prep via WRBY's SEC 10-K and 10-Q filings.

WRBY PE ratioWhat is WRBY PE ratioCurrent PE ratio of WRBYWRBY PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Warby Parker Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08